prostatic cancersとは 意味・読み方・使い方

In particular, CCI-779 is useful for the treatment of renal cancers, soft tissue tumors, breast cancers, neuroendocrine tumors of lungs, cancers of cervix, cancers of uterus, head and neck cancers, neuroblastomas, non-small cell lung cancers, prostatic cancers, pancreatic cancers, lymphomas, melanomas, small cell lung cancers, ovarian cancers or colon cancers.例文帳に追加

特に、ＣＣＩ−７７９は、腎臓癌、軟部組織癌、乳癌、肺の神経内分泌性腫瘍、子宮頚癌、子宮癌、頭頚部癌、神経膠芽細胞腫、非小細胞肺癌、前立腺癌、膵臓癌、リンパ腫、黒色腫、小細胞肺癌、卵巣癌または結腸癌の治療に有用である。 - 特許庁

To obtain a new compound useful for treating various sex hormone- related symptoms, especially gonadotropin-releasing hormone derived disorders such as sex hormone-dependent cancers, benign prostatic hyperplasia or uterine myoma.例文帳に追加

種々の性ホルモン関連症状及びその他の症状の治療に有用な医薬組成物の提供。 - 特許庁

The radiation effect-reinforcing agent comprises as an effective ingredient a compound represented by formula (1) or a salt thereof and is employed in the radiotherapy of tumors, particularly gastrointestinal tumors, kidney cancers, prostatic cancers, malignant lymphoma, or the like.例文帳に追加

で表される化合物又はその塩を有効成分として含有する腫瘍、特に胃腸管腫瘍、腎臓癌、前立腺癌、及び悪性リンパ腫などの放射線療法における放射線効果増強剤。 - 特許庁

To provide a method for identifying and confirming prostatic intraepithelial neoplasia, a method for determining metastatic potential of tumors and a method for inhibiting or preventing metastasis of cancers.例文帳に追加

前立腺上皮内新形成を同定、確認する方法、腫瘍の転移可能性を測定する方法および癌の転移を抑制または予防する方法の提供。 - 特許庁

The TGF-β signal transmission mechanism inhibitor is useful for treating and researching cancers (breast cancer, lung cancer, uterine cancer, prostatic cancer, pancreatic cancer, melanoma), pulmonary fibrosis, renal fibrosis, and hepatocirrhosis.例文帳に追加

TGF-βシグナル伝達機構を制御する物質は、癌（乳癌、肺癌、子宮癌、前立腺癌、膵臓癌、メラノーマ）、肺線維化症、腎線維化症、及び肝硬変の治療、研究に有用である。 - 特許庁

The medicinal composition for treating or preventing cancers (excluding prostatic cancer) contains a peptide binding to an HLA-A24 molecule and originating in a parathyroid hormone-related protein or its derivative having functionally the same properties.例文帳に追加

本発明は、HLA-A24分子結合性副甲状腺ホルモン関連蛋白由来ペプチドまたは機能的に同等の性質を有するその誘導体を含む、癌（但し前立腺癌を除く）を処置または予防するための医薬組成物を提供する。 - 特許庁

To provide a food, a pharmaceutical formulation and an animal food useful for therapy and prophylaxis of various disorders originated from low adiponectinemia, insulin resistance sthenia or the like (for example, metabolic syndrome, diabetes and its complication, non-alcoholic fat hepatitis (NASH) and hepatic disease origined from it, and cancers such as endometrial carcinoma, breast carcinoma after menopause, leukemia, colon cancer, stomach cancer and prostatic cancer).例文帳に追加

低アディポネクチン血症、インスリン抵抗性亢進等に由来する各種疾患（例えば、メタボリックシンドローム、糖尿病およびその合併症、非アルコール性脂肪肝炎（ＮＡＳＨ）およびそれに由来する肝疾患、子宮内膜癌、閉経後乳癌、白血病、大腸癌、胃癌、前立腺癌等の癌）の治療・予防に役立つ食品、医薬製剤、飼料を提供する。 - 特許庁